Upside Foods vs Oura

Side-by-side comparison of AI visibility scores, market position, and capabilities

Upside Foods

EmergingFood, Beverage & AgTech

Cultivated Meat

First US-approved cultivated meat company; $612M raised, USDA and FDA clearance in 2023, pioneering cell-cultivated chicken for commercial sale.

About

Upside Foods (formerly Memphis Meats) is a Berkeley, California-based cultivated meat company founded in 2015 by Dr. Uma Valeti, Nicholas Genovese, and Will Clem. The company produces chicken directly from animal cells without slaughter, using bioreactor-based cell cultivation. In June 2023, Upside Foods and GOOD Meat became the first US companies to receive USDA approval to sell cultivated meat commercially — a historic regulatory milestone for the food technology industry.\n\nUpside Foods has raised $612 million across seven funding rounds from investors including Tyson Foods, Cargill, Softbank Vision Fund, Bill Gates, and Richard Branson, at a valuation of approximately $1 billion. Commercial sales launched through a partnership with Michelin-starred chef Dominique Crenn at Bar Crenn in San Francisco, followed by additional restaurant partners. The company's engineering-grade production facility in Emeryville, California serves as both a pilot plant and a showcase for the cultivation technology.\n\nUpside Foods faces the significant challenge of scaling bioreactor production to commercially competitive costs. While regulatory approval is secured, food scientists estimate that cost parity with conventional chicken will require several additional years of manufacturing innovation. The company is widely regarded as the most technically advanced cultivated meat player in the US.

Full profile

Oura

LeaderConsumer Tech

Smart Health Wearables

Raised $900M Series E at $11B valuation (Oct 2025). CEO projects ~$2B in 2026 sales. Launched women's health LLM (Feb 2026). Team USA LA28 Olympic partner.

About

Oura is the maker of the Oura Ring, a premium smart ring that tracks sleep, recovery, readiness, and health metrics through continuous biometric sensing. The company raised $900 million in Series E financing at an $11 billion valuation in October 2025, reflecting the doubling of its revenue to $500 million in 2024 and a projected $1.5–2 billion in 2026 sales as it expands global distribution into India, UAE, and Latin America.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.